In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model

<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer is the fourth leading cause of tumour death in the western world. However, appropriate tumour models are scarce. Here we present a syngeneic murine pancreatic cancer model using 7 Tesla MRI and evaluate its clinical relevance and applicability.</p> <p>Methods</p> <p>6606PDA murine pancreatic cancer cells were orthotopically injected into the pancreatic head. Liver metastases were induced through splenic injection. Animals were analyzed by MRI three and five weeks following injection. Tumours were detected using T2-weighted high resolution sequences. Tumour volumes were determined by callipers and MRI. Liver metastases were analyzed using gadolinium-EOB-DTPA and T1-weighted 3D-Flash sequences. Tumour blood flow was measured using low molecular gadobutrol and high molecular gadolinium-DTPA.</p> <p>Results</p> <p>MRI handling and applicability was similar to human systems, resolution as low as 0.1 mm. After 5 weeks tumour volumes differed significantly (p < 0.01) when comparing calliper measurments (n = 5, mean 1065 mm³+/-243 mm³) with MRI (mean 918 mm³+/-193 mm³) with MRI being more precise. Histology (n = 5) confirmed MRI tumour measurements (mean size MRI 38.5 mm²+/-22.8 mm²versus 32.6 mm²+/-22.6 mm²(histology), p < 0,0004) with differences due to fixation and processing of specimens. After splenic injection all mice developed liver metastases with a mean of 8 metastases and a mean volume of 173.8 mm³+/-56.7 mm³after 5 weeks. Lymphnodes were also easily identified. Tumour accumulation of gadobutrol was significantly (p < 0.05) higher than gadolinium-DTPA. All imaging experiments could be done repeatedly to comply with the 3R-principle thus reducing the number of experimental animals.</p> <p>Conclusions</p> <p>This model permits monitoring of tumour growth and metastasis formation in longitudinal non-invasive high-resolution MR studies including using contrast agents comparable to human pancreatic cancer. This multidisciplinary environment enables radiologists, surgeons and physicians to further improve translational research and therapies of pancreatic cancer.</p

Einsatz der mobilen Computertomographie in der Intensivmedizin

Thema: Ziel der Studie war die Evaluierung der mobilen CT im intensivmedizinischen Einsatz Methodik: Es wurde eine Prozessanalyse der mobilen CT in einem Interventionsraum auf der Intensivstation sowie der ortsfesten CT in der radiologischen Abteilung vorgenommen. Der klinische Teil richtete sich auf die Evaluierung des intensivmedizinischen Personals bezüglich der Bewertung der mobilen CT. Weiterhin wurden die mit der mobilen CT untersuchten Patienten hinsichtlich ihrer Transportfähigkeit anhand intensivmedizinischer Bewertungssysteme bewertet. Ergebnisse: Die CT-Untersuchungen mit der mobilen CT im Interventionsraum haben einen leichten zeitlichen Vorteil gegenüber denen in der radiologischen Abteilung (55 vs 65 Minuten). Die mobile CT wurde von der Mehrheit des intensivmedizinischen Personals positiv bewertet, z.B. empfanden sie 81 % der Ärzte sowie mehr als 50 % der Pflegekräfte als Arbeitserleichterung. Bei vier der 24 untersuchten Patienten hätte es keine Alternative zur mobilen CT gegeben. Schlussfolgerung: Die mobile CT hat sich im klinischen Einsatz bewährt. Sie gewährleistet eine kontinuierliche intensivmedizinische Umgebung bei der CT-Untersuchung. Darüber hinaus ermöglicht sie bei nicht transportfähigen Patienten eine adäquate radiologische Diagnostik.Purpose: To evaluate portable CT in ICU settings. Methods: Assessment of workflow of portable and stationary CT. Evaluation of ICU staff by questionnaire. Risk of transportation Assessment of examined patients by ICU-scores). Results: Examination by portable CT is little less time consuming compared to CT-examination in the radiology department (55 vs. 65 minutes). There was a great acceptance of portable CT by ICU staff. 81 % of ICU physicians and more than 50 % of nurses assessed portable CT as a reduction of work load. Portable CT could not have been missed in four of 24 examined patients for examination by computed tomography. Conclusions: Portable CT enables ICU-care to be continued during CT-examination. By Bedside CT patients can be examined who otherwise would have to abandon advanced radiologic diagnostic

Modification of Aminosilanized Superparamagnetic Nanoparticles: Feasibility of Multimodal Detection Using 3T MRI, Small Animal PET, and Fluorescence Imaging

The aim of our study was to modify an aminosilane-coated superparamagnetic nanoparticle for cell labeling and subsequent multimodal imaging using magnetic resonance imaging (MRI), positron emission tomography (PET), and fluorescent imaging in vivo

Imaging of primary human hepatocytes performed with micron-sized iron oxide particles and clinical magnetic resonance tomography

Transplantation of primary human hepatocytes is a promising approach in certain liver diseases. For the visualization of the hepatocytes during and following cell application and the ability of a timely response to potential complications, a non-invasive modality for imaging the transplanted cells has to be established. The aim of this study was to label primary human hepatocytes with micron-sized iron oxide particles (MPIOs), enabling the detection of cells by clinical magnetic resonance imaging (MRI). Primary human hepatocytes isolated from 13 different donors were used for the labelling experiments. Following the dose-finding studies, hepatocytes were incubated with 30 particles/cell for 4 hrs in an adhesion culture. Particle incorporation was investigated via light, fluorescence and electron microscopy, and labelled cells were fixed and analysed in an agarose suspension by a 3.0 Tesla MR scanner. The hepatocytes were enzymatically resuspended and analysed during a 5-day reculture period for viability, total protein, enzyme leakage (aspartate aminotransferase [AST], lactate dehydrogenase [LDH]) and metabolic activity (urea, albumin). A mean uptake of 18 particles/cell could be observed, and the primary human hepatocytes were clearly detectable by MR instrumentation. The particle load was not affected by resuspension and showed no alternations during the culture period. Compared to control groups, labelling and resuspension had no adverse effects on the viability, enzyme leakage and metabolic activity of the human hepatocytes. The feasibility of preparing MPIO-labelled primary human hepatocytes detectable by clinical MR equipment was shown in vitro. MPIO-labelled cells could serve for basic research and quality control in the clinical setting of human hepatocyte transplantation